Novartis Seeks To Stop Hospira From Selling Zometa Generic

By Kelly Knaub (August 6, 2013, 4:52 PM EDT) -- Novartis Pharmaceuticals Corp. launched a lawsuit against Hospira Inc. in New Jersey federal court Friday seeking to block the company's attempt to manufacture and sell generic versions of Novartis' cancer therapy drug Zometa prior to expiration of two of its patents. ...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!